Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Lowers Stock Position in Intuitive Surgical, Inc. $ISRG

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 32.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,045 shares of the medical equipment provider’s stock after selling 3,780 shares during the quarter. Intuitive Surgical comprises approximately 1.7% of Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s portfolio, making the stock its 13th biggest position. Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s holdings in Intuitive Surgical were worth $4,556,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. SouthState Bank Corp lifted its position in Intuitive Surgical by 2.9% during the fourth quarter. SouthState Bank Corp now owns 45,350 shares of the medical equipment provider’s stock valued at $25,684,000 after buying an additional 1,277 shares during the period. Syon Capital LLC lifted its position in Intuitive Surgical by 16.9% during the fourth quarter. Syon Capital LLC now owns 5,523 shares of the medical equipment provider’s stock valued at $3,128,000 after buying an additional 800 shares during the period. Capital World Investors lifted its position in Intuitive Surgical by 1.7% during the fourth quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock valued at $4,449,491,000 after buying an additional 127,526 shares during the period. Capital International Sarl lifted its position in Intuitive Surgical by 6.1% during the fourth quarter. Capital International Sarl now owns 114,521 shares of the medical equipment provider’s stock valued at $64,860,000 after buying an additional 6,598 shares during the period. Finally, Capital International Ltd. CA lifted its position in Intuitive Surgical by 1.7% during the fourth quarter. Capital International Ltd. CA now owns 65,276 shares of the medical equipment provider’s stock valued at $36,970,000 after buying an additional 1,074 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on ISRG. Jefferies Financial Group lowered their price target on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a research report on Wednesday, April 22nd. HSBC lowered their price target on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. The Goldman Sachs Group set a $558.00 price target on Intuitive Surgical in a research report on Wednesday, May 27th. Citigroup raised Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target for the company in a research report on Wednesday, March 11th. Finally, Leerink Partners lowered their price target on Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a research report on Wednesday, April 22nd. Nineteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $573.63.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 645 shares of Intuitive Surgical stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the completion of the sale, the senior vice president directly owned 1,613 shares in the company, valued at approximately $782,321.13. This trade represents a 28.57% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares of the company’s stock, valued at $2,718,014.65. The trade was a 46.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,448 shares of company stock worth $3,224,404 in the last three months. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $422.06 on Friday. Intuitive Surgical, Inc. has a one year low of $396.68 and a one year high of $603.88. The stock has a 50-day moving average of $447.24 and a 200 day moving average of $501.02. The company has a market capitalization of $149.48 billion, a price-to-earnings ratio of 51.16, a PEG ratio of 3.37 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. During the same period last year, the company earned $1.81 EPS. Intuitive Surgical’s revenue for the quarter was up 23.0% on a year-over-year basis. On average, equities analysts predict that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.